Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-25 @ 5:01 PM
Study NCT ID:
NCT00151203
Status:
COMPLETED
Last Update Posted:
2021-05-27
First Post:
2005-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
Sponsor:
Weill Medical College of Cornell University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-12
Start Date Type:
ACTUAL
Primary Completion Date:
2007-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-29
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-06
First Submit QC Date:
None
Study First Post Date:
2005-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-26
Last Update Post Date:
2021-05-27
Last Update Post Date Type:
ACTUAL